(MedPage Today) — Use of disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) was markedly lower among all major racial-ethnic minority groups in the U.S. compared with white patients, analysis of federal survey data indicated…
Source link : https://www.medpagetoday.com/rheumatology/arthritis/118792
Author :
Publish date : 2025-12-02 19:01:00
Copyright for syndicated content belongs to the linked Source.









